KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Discontinued Operations (2016)

Historic Cash from Discontinued Operations for Fulgent Genetics (FLGT) over the last 2 years, with Q2 2016 value amounting to -$14000.0.

  • Fulgent Genetics' Cash from Discontinued Operations changed N/A to -$14000.0 in Q2 2016 from the same period last year, while for Dec 2016 it was -$31000.0, marking a year-over-year change of. This contributed to the annual value of -$31000.0 for FY2016, which is 9896.49% up from last year.
  • Latest data reveals that Fulgent Genetics reported Cash from Discontinued Operations of -$14000.0 as of Q2 2016.
  • In the past 5 years, Fulgent Genetics' Cash from Discontinued Operations ranged from a high of -$14000.0 in Q2 2016 and a low of -$916000.0 during Q4 2015